Anteris Technologies Ltd
(FRA:DDF)
€
5.1
0 (-8.93%)
Market Cap: 34.67 Mil
Enterprise Value: 29.09 Mil
PE Ratio: 0
PB Ratio: 39.15
GF Score: 43/100 Anteris Technologies Ltd at EuroPCR 2023 Physician Panel Transcript
May 16, 2023 - May 19, 2023 / NTS GMT
Susheel Kodali
Columbia University - Director, Structural Heart & Valve Center
Hello, welcome everyone. My name is Susheel Kodali from Columbia University in New York. It's great to be back in Paris in EuroPCR. We have an exciting discussion today talking about the early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve called DurAVR.
I'm joined by my friends and colleagues, Chris Meduri from Karolinska University in Stockholm, and João Cavalcante from Minneapolis Heart Institute. So welcome, Chris. Joe, welcome.
Chris Meduri
Anteris Technologies Ltd - Chief Medical Officer
Thank you.
JoÃ;o Cavalcante
Minneapolis Heart Institute - Director, Cardiac MRI, Structural CT & Cardiovascular Imaging Core Lab
£ -
Thank you, Susheel.
Susheel Kodali
Columbia University - Director, Structural Heart & Valve Center
So we want to start a little bit -- I mean, TAVR over the last 15 years has really evolved
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot